Intravitreal bevacizumab for a subfoveal myopic choroidal neovascularization in the first trimester of pregnancy

Journal of Ocular Pharmacology and Therapeutics

Volumn 28, Issue 5, 2012, Pages 553-555

  Introini, Ugo ^a   Casalino, Giuseppe ^a   Cardani, Anna ^a   Scotti, Fabrizio ^a   Finardi, Alberto ^b   Candiani, Massimo ^a   Bandello, Francesco ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

ADULT; ARTICLE; BIOMICROSCOPY; BLURRED VISION; CASE REPORT; EXAMINATION; FEMALE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; FLUORESCENCE ANGIOGRAPHY; GESTATIONAL AGE; HUMAN; MYOPIA; OBSERVATIONAL STUDY; OPHTHALMOSCOPY; RETINA MACULA EDEMA; RETINA MACULA HEMORRHAGE; SINGLE DRUG DOSE; SLIT LAMP; SUBFOVEAL MYOPIC CHOROIDAL NEOVASCULARIZATION; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

ADULT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; APGAR SCORE; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOVEA CENTRALIS; HUMANS; INFANT, NEWBORN; INTRAVITREAL INJECTIONS; MYOPIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 84865081813     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2012.0067     Document Type: Article

References (12)

1. Kobayashi, K., Mandai, M., Suzuma, I., Kobayashi, H., and Okinami, S. Expression of estrogen receptor in the choroidal neovascular membranes in highly myopic eyes. Retina 22:418-422, 2002.
2. Rhee, P., Dev, S., and Mieler, W.F. The development of choroidal neovascularization in pregnancy. Retina 19:520-524, 1999.
3. Cohen, S.Y. Anti-VEGF drugs as the 2009 first-line therapy for choroidal neovascularization in pathologic myopia. Retina 29:1062-1066, 2009.
4. Bakri, S.J., Snyder, M.R., Reid, J.M., Pulido, J.S., and Singh, R.J. Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology 114:855-859, 2007.
5. Sane, D.C., Anton, L., and Brosnihan, K.B. Angiogenic growth factors and hypertension. Angiogenesis 7:193-201, 2004.
6. Rosen, E., Rubowitz, A., and Ferencz, J.R. Exposure to verteporfin and bevacizumab therapy for choroidal neovascularization secondary to punctate inner choroidopathy during pregnancy. Eye (Lond) 23:1479, 2009.
7. Petrou, P., Georgalas, I., Giavaras, G., Anastasiou, E., Ntana, Z., and Petrou, C. Early loss of pregnancy after intravitreal bevacizumab injection. Acta Ophthalmol. 88:e136, 2010.
8. Tarantola, R.M., Folk, J.C., Boldt, H.C., and Mahajan, V.B. Intravitreal bevacizumab during pregnancy. Retina 30:1405-1411, 2010.
9. Wu, Z., Huang, J., and Sadda, S. Inadvertent use of bevacizumab to treat choroidal neovascularisation during pregnancy: a case report. Ann. Acad. Med. Singapore 39:143, 2010.
10. Final labeling text, highlights of prescribing information. U.S.BL 125085/168 Amendment: Bevacizumab-Genentech, Inc. Updated July 2009. South San Francisco, CA: Genentech, Inc. www.gene.com/gene/products/information/pdf/ avastinprescribing.pdf. Accessed September 10, 2010.
11. Blinder, K.J., Blumenkranz, M.S., Bressler, N.M., Bressler, S.B., Donato, G., Lewis, H., et al. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial-VIP report no. 3. Ophthalmology 110:667-673, 2003.
12. Martin, D.F., Maguire, M.G., Ying, G.S., Grunwald, J.E., Fine, S.L., and Jaffe, G.J. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 364:1897-1908, 2011.